NUVL Q4 2022 Earnings — Nuvalent, Inc. Revenue & Financial Results | Market Cap Arena

NUVLNuvalent, Inc.

$8B

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$29M

Net Income

-$26M

EPS (Diluted)

$-0.49

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$18M

Free Cash Flow

-$18M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$482M

Total Liabilities

$19M

Stockholders' Equity

$463M

Cash & Equivalents

$242M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$29M	-$17M	-68.6%
Net Income	-$26M	-$17M	-51.1%